The FDA is considering authorizing this year's COVID-19 vaccines due to a significant summer wave, with high levels of SARS-CoV-2 detected in wastewater across numerous states.
The surge in COVID-19 this summer peaked higher than in previous years, with test positivity rates reflecting levels not seen since the early omicron wave.
Despite the rise in cases, emergency department visits and deaths attributed to COVID-19 remain low, showcasing benefits from previous vaccinations and infections.
The FDA's strategy has shifted to annual COVID-19 vaccinations in the winter, while still monitoring the serious summer wave leading to potential early authorizations.
[
Collection
]
[
|
...
]